Towards novel 5-HT7 versus 5-HT1A receptor ligands among LCAPs with cyclic amino acid amide fragments: Design, synthesis, and antidepressant properties. Part II

This publication has 30 references indexed in Scilit:

• Selective agonists for serotonin 7 (5-HT₇) receptor and their applications in preclinical models: an overview
  Reviews in the Neurosciences, 2014
• Developing new pharmacotherapies for autism
  Journal of Internal Medicine, 2013
• Activation of 5-HT7 Serotonin Receptors Reverses Metabotropic Glutamate Receptor-Mediated Synaptic Plasticity in Wild-Type and Fmr1 Knockout Mice, a Model of Fragile X Syndrome
  Biological Psychiatry, 2012
• Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders
  Trends in Pharmacological Sciences, 2012
• Role of peripheral versus spinal5‐HT₇receptors in the modulation of pain undersensitizing conditions
  European journal of pain, 2012
• Role of the 5-HT7 Receptor in the Central Nervous System: from Current Status to Future Perspectives
  Molecular Neurobiology, 2011
• Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice
  European Journal of Pharmacology, 2007
• Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression
  Neuropharmacology, 2005
• Functional, molecular and pharmacological advances in 5-HT receptor research
  Trends in Pharmacological Sciences, 2004
• Arylpiperazine Derivatives Acting at 5-HT1A Receptors
  Current Medicinal Chemistry, 2002